CTI BioPharma (CTIC) Reports Q2 EPS of $0.03

August 3, 2017 4:02 PM

CTI BioPharma (NASDAQ: CTIC) reported Q2 EPS of $0.03, versus ($0.71) reported last year.

For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.

Categories

Earnings Guidance